top of page


Genpax Estimates Significant Cost Savings, Health Benefits From WGS Infection Surveillance
NEW YORK – Bioinformatics company Genpax estimates that healthcare systems can save considerable money while preventing infection outbreaks through microbial whole-genome sequencing. In a study published earlier this month in Microbial Genetics, the London-based company calculated that implementing a WGS surveillance strategy could prevent some 74,000 infections annually in England, saving the National Health Service approximately £480 million ($604.5 million) per year, amoun
Sep 7, 20235 min read
bottom of page
